Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Plandai Biotechnology, Inc. (OTC: PLPL).

Full DD Report for PLPL

You must become a subscriber to view this report.


Recent News from (OTC: PLPL)

Plandai Biotechnology Addresses Opportunities in the South African and Global Poultry Industries
Increased Interest in Phytogenics affording Improved Gut Maintenance in Chickens LONDON, UNITED KINGDOM, May 16, 2018 (GLOBE NEWSWIRE) -- Plandai Biotechnology Inc. (OTC Markets: PLPL) (the “Company” or “Plandai”), a producer of nutraceutical and highly phy...
Source: GlobeNewswire
Date: May, 16 2018 08:30
Plandai Biotechnology's Phytofare Gaining Traction in International Markets
2018 Focus for U.S. Expansion After Initial Success with NutriBullet LONDON, UNITED KINGDOM, May 09, 2018 (GLOBE NEWSWIRE) -- Plandai Biotechnology, Inc. (OTC Markets:  PLPL ) (the “Company” or “Plandai”), a producer of nutraceutical and highly phy...
Source: GlobeNewswire
Date: May, 09 2018 08:30
Plandai Biotechnology's Phytofare® Utilizes Green Tea to Fight Type 2 Diabetes
Highly Bioavailable Formulation Efficiently Transfers Antioxidants LONDON, UNITED KINGDOM, May 03, 2018 (GLOBE NEWSWIRE) -- Plandai Biotechnology Inc. (OTC Markets: PLPL) (the “Company” or “Plandai”), a producer of nutraceutical and highly phyto-available e...
Source: GlobeNewswire
Date: May, 03 2018 08:30
Plandai Biotechnology Discusses How Green Tea Combats Type 2 Diabetes
Natural Solution Provides Positive Mitigation Against Type 2 Diabetes LONDON, UNITED KINGDOM, May 01, 2018 (GLOBE NEWSWIRE) -- Plandai Biotechnology Inc. (OTC Markets: PLPL) (the “Company” or “Plandai”), a producer of nutraceutical and highly phyto-availabl...
Source: GlobeNewswire
Date: May, 01 2018 07:30
Plandai Biotechnology Provides Background on its Past and Present Cannabis Initiatives
Company History in Cannabis Research Dates Back to February 2013 LONDON, UNITED KINGDOM, April 25, 2018 (GLOBE NEWSWIRE) -- Plandai Biotechnology Inc. (OTC Markets: PLPL) (the “Company” or “Plandai”), a producer of nutraceutical and highly phyto-available e...
Source: GlobeNewswire
Date: April, 25 2018 08:30
Plandai Biotechnology Discusses Cannabis Strategy, Research and Business
LONDON, UNITED KINGDOM , April 19, 2018 (GLOBE NEWSWIRE) -- Plandai Biotechnology Inc. (OTC Markets:  PLPL ) (the “Company” or “Plandai”), a producer of nutraceutical and highly phyto-available extracts, is pleased to provide an update on its cannabis busine...
Source: GlobeNewswire
Date: April, 19 2018 08:30
Plandai Biotechnology Provides Update on its Convertible Debt
Previously Issued Convertible Notes Now in Friendly Shareholder Hands LONDON, UNITED KINGDOM, April 12, 2018 (GLOBE NEWSWIRE) -- Plandai Biotechnology Inc. (OTC Markets: PLPL) (the “Company” or “Plandai”), a producer of nutraceutical and highly phyto-availa...
Source: GlobeNewswire
Date: April, 12 2018 08:00
Plandai Biotechnology Addresses Bioavailability and the Science of Phytofare
Human Clinical Trial Results and Key Benefits Phytofare Catechin Complex is Superior to Generic Green Tea Extracts LONDON, UNITED KINGDOM, April 10, 2018 (GLOBE NEWSWIRE) -- Plandai Biotechnology Inc. (OTC Markets: PLPL) (the “Company” or “Plandai”), ...
Source: GlobeNewswire
Date: April, 10 2018 08:30
Plandai Biotechnology Provides Update to Its Proprietary Technology
Phytofare Clinically Proven to Dramatically Improve Absorption LONDON, UNITED KINGDOM, April 03, 2018 (GLOBE NEWSWIRE) -- Plandai Biotechnology Inc. (OTC Markets: PLPL) (the “Company” or “Plandai”), a producer of nutraceutical and highly phyto-available ext...
Source: GlobeNewswire
Date: April, 03 2018 08:30
Plandai Biotechnology Appoints Paritz & Company as New Auditor
Performing Two Year Audit for Plandaí to Become Current and SEC Compliant LONDON, UNITED KINGDOM , March 27, 2018 (GLOBE NEWSWIRE) --   Plandaí Biotechnology Inc. (OTC Markets:  PLPL ) (the “Company” or “Plandai”), a producer of nutraceu...
Source: GlobeNewswire
Date: March, 27 2018 08:30

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-08-160.00650.00550.00650.0055573,000
2018-08-150.00410.00580.00650.00412,187,269
2018-08-140.006450.0060.006450.0053481,598
2018-08-130.00570.00560.0060.00521,389,366
2018-08-100.00570.006570.00690.0057494,252

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-15446,2002,560,06917.4292Cover
2018-08-14423,766481,59887.9916Short
2018-08-13770,4731,389,36655.4550Short
2018-08-10146,651494,25229.6713Cover
2018-08-09422,8211,464,67828.8678Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on PLPL.


About Plandai Biotechnology, Inc. (OTC: PLPL)

Logo for Plandai Biotechnology, Inc. (OTC: PLPL)

Plandai Biotechnology, Inc. and its subsidiaries develop highly bioavailable, phytonutrient rich extracts which are being utilized to deliver a new family of drugs to safely and affordably treat a multitude of diseases and conditions. Plandai Biotechnology, through its South African subsidiaries, controls every aspect of production, from growing specific raw materials such as green tea on its farms to producing its proprietary Phytofare extract, allowing the Company to guarantee the continuity of supply as well as quality control throughout the entire process. The manufacturing facility has also been engineered for citrus fruits and the recovery of limonoids. Targeted industries for the Company s products include beverage, cosmeceutical, wellness, nutraceutical, anti aging, and pharmaceutical. For more information, please visit http://www.plandaibiotech.com

 

Contact Information

 

 

Current Management

  • Roger Baylis Duffield / CEO, CFO
  • Callum BaylisDuffield / VP, Sales amp Mktg., Corporate Secretary
  • Hannah Merrill / IR
  • Roger Baylis Duffield / Chairman
  • Callum BaylisDuffield /
  • Daron BaylisDuffield /
  • Brian Johnson /

Current Share Structure

  • Market Cap: $2,406,253 - 03/09/2018
  • Authorized: 500,000,000 - 12/31/2011
  • Issue and Outstanding: 186,531,236 - 08/15/2016

 


Recent Filings from (OTC: PLPL)

Quarterly Report - Quarterly Report
Filing Type: Quarterly Report - Quarterly ReportFiling Source: OTC Markets
Filing Date: February, 20 2018
Statement of beneficial ownership of common stock by certain persons
Filing Type: SC 13GFiling Source: edgar
Filing Date: February, 14 2018
Notification of Late Filing - Notification of Late Filing
Filing Type: Notification of Late Filing - Notification of Late FilingFiling Source: OTC Markets
Filing Date: February, 14 2018
Quarterly Report - Quarterly Report
Filing Type: Quarterly Report - Quarterly ReportFiling Source: OTC Markets
Filing Date: November, 20 2017
Notification of Late Filing - Notification of Late Filing
Filing Type: Notification of Late Filing - Notification of Late FilingFiling Source: OTC Markets
Filing Date: November, 14 2017
Annual Report - Annual Report
Filing Type: Annual Report - Annual ReportFiling Source: OTC Markets
Filing Date: October, 16 2017
Notification of Late Filing - Notification of Late Filing
Filing Type: Notification of Late Filing - Notification of Late FilingFiling Source: OTC Markets
Filing Date: September, 25 2017
Quarterly Report - Quarterly Report
Filing Type: Quarterly Report - Quarterly ReportFiling Source: OTC Markets
Filing Date: May, 22 2017
Notification of Late Filing - Notification of Late Filing
Filing Type: Notification of Late Filing - Notification of Late FilingFiling Source: OTC Markets
Filing Date: May, 15 2017
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: April, 24 2017

 

 


Daily Technical Chart for (OTC: PLPL)

Daily Technical Chart for (OTC: PLPL)


Stay tuned for daily updates and more on (OTC: PLPL)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: PLPL)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in PLPL is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of PLPL and does not buy, sell, or trade any shares of PLPL. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/